Climb Bio, Inc. (CLYM) Operating income 2020–2025
Climb Bio, Inc. (CLYM) annual operating income history from SEC filings — each fiscal year as reported.
-$67.9MFY2025 · since FY2020: -$20.9M → -$67.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$67.9M | +17.2% |
| FY2024 | -$82.0M | -103.6% |
| FY2023 | -$40.3M | +10.8% |
| FY2022 | -$45.1M | -26.5% |
| FY2021 | -$35.7M | -70.5% |
| FY2020 | -$20.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice